Applied Clinical Trials podcast

ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data

0:00
1:47
15 Sekunden vorwärts
15 Sekunden vorwärts
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.

Weitere Episoden von „Applied Clinical Trials“